Effects of somatostatin-14 and somatostatin-28 on plasma hormonal and gastric secretory responses to cephalic and gastrointestinal stimulation in man

S. J. Konturek, N. Kwiecie, W. Obtuowicz, W. Bielaski, J. Oleksy, Andrew V Schally

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

This study was designed to determine the influence of cephalic and gastrointestinal meal stimulation on plasma levels of somatostatin-like immunoreactivity (SLI) and to compare plasma hormonal and gastric secretory effects of somatostatin-14 (SS-14) and its putative prohormone, somatostatin-28 (SS-28), in humans. Cephalic stimulation induced by modified sham feeding did not affect plasma SLI, whereas a gastric liver extract meal caused a significant increase in SLI. Infusion of SS-28 dose-dependently suppressed gastric acid, serum gastrin, and plasma pancreatic polypeptide (PP) responses to cephalic and gastrointestinal stimulation. SS-28 was equipotent with SS-14 as gastric inhibitor when compared on the basis of molar doses infused but was 4-10 times less potent on the basis of plasma SLI concentrations obtained. A lower and more physiological dose of SS-14 (75 pmol/kg-h) reduced gastric acid and PP responses but failed to affect the serum gastrin response to a meal, whereas a larger, pharmacological dose (500 pmol/kg-h) also suppressed serum gastrin responses. We conclude that meal releases SLI into the circulation and that SS-28 mimics the gastric secretory and plasma hormonal effects of SS-14 but is several times less potent than SS-14 in terms of circulating hormone levels.

Original languageEnglish
Pages (from-to)31-38
Number of pages8
JournalScandinavian Journal of Gastroenterology
Volume20
Issue number1
DOIs
StatePublished - Jan 1 1985
Externally publishedYes

Fingerprint

Somatostatin-28
Somatostatin
Stomach
Head
Meals
Gastrins
Pancreatic Polypeptide
Gastric Acid
Serum
Liver Extracts
somatostatin-like peptides
Hormones
Pharmacology

Keywords

  • Cephalic phase
  • Gastric secretion
  • Gastrointestinal hormones
  • Somatostatin

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Effects of somatostatin-14 and somatostatin-28 on plasma hormonal and gastric secretory responses to cephalic and gastrointestinal stimulation in man. / Konturek, S. J.; Kwiecie, N.; Obtuowicz, W.; Bielaski, W.; Oleksy, J.; Schally, Andrew V.

In: Scandinavian Journal of Gastroenterology, Vol. 20, No. 1, 01.01.1985, p. 31-38.

Research output: Contribution to journalArticle

@article{92f62c3361984eb8ae5862a901d969b3,
title = "Effects of somatostatin-14 and somatostatin-28 on plasma hormonal and gastric secretory responses to cephalic and gastrointestinal stimulation in man",
abstract = "This study was designed to determine the influence of cephalic and gastrointestinal meal stimulation on plasma levels of somatostatin-like immunoreactivity (SLI) and to compare plasma hormonal and gastric secretory effects of somatostatin-14 (SS-14) and its putative prohormone, somatostatin-28 (SS-28), in humans. Cephalic stimulation induced by modified sham feeding did not affect plasma SLI, whereas a gastric liver extract meal caused a significant increase in SLI. Infusion of SS-28 dose-dependently suppressed gastric acid, serum gastrin, and plasma pancreatic polypeptide (PP) responses to cephalic and gastrointestinal stimulation. SS-28 was equipotent with SS-14 as gastric inhibitor when compared on the basis of molar doses infused but was 4-10 times less potent on the basis of plasma SLI concentrations obtained. A lower and more physiological dose of SS-14 (75 pmol/kg-h) reduced gastric acid and PP responses but failed to affect the serum gastrin response to a meal, whereas a larger, pharmacological dose (500 pmol/kg-h) also suppressed serum gastrin responses. We conclude that meal releases SLI into the circulation and that SS-28 mimics the gastric secretory and plasma hormonal effects of SS-14 but is several times less potent than SS-14 in terms of circulating hormone levels.",
keywords = "Cephalic phase, Gastric secretion, Gastrointestinal hormones, Somatostatin",
author = "Konturek, {S. J.} and N. Kwiecie and W. Obtuowicz and W. Bielaski and J. Oleksy and Schally, {Andrew V}",
year = "1985",
month = "1",
day = "1",
doi = "10.3109/00365528509089629",
language = "English",
volume = "20",
pages = "31--38",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Effects of somatostatin-14 and somatostatin-28 on plasma hormonal and gastric secretory responses to cephalic and gastrointestinal stimulation in man

AU - Konturek, S. J.

AU - Kwiecie, N.

AU - Obtuowicz, W.

AU - Bielaski, W.

AU - Oleksy, J.

AU - Schally, Andrew V

PY - 1985/1/1

Y1 - 1985/1/1

N2 - This study was designed to determine the influence of cephalic and gastrointestinal meal stimulation on plasma levels of somatostatin-like immunoreactivity (SLI) and to compare plasma hormonal and gastric secretory effects of somatostatin-14 (SS-14) and its putative prohormone, somatostatin-28 (SS-28), in humans. Cephalic stimulation induced by modified sham feeding did not affect plasma SLI, whereas a gastric liver extract meal caused a significant increase in SLI. Infusion of SS-28 dose-dependently suppressed gastric acid, serum gastrin, and plasma pancreatic polypeptide (PP) responses to cephalic and gastrointestinal stimulation. SS-28 was equipotent with SS-14 as gastric inhibitor when compared on the basis of molar doses infused but was 4-10 times less potent on the basis of plasma SLI concentrations obtained. A lower and more physiological dose of SS-14 (75 pmol/kg-h) reduced gastric acid and PP responses but failed to affect the serum gastrin response to a meal, whereas a larger, pharmacological dose (500 pmol/kg-h) also suppressed serum gastrin responses. We conclude that meal releases SLI into the circulation and that SS-28 mimics the gastric secretory and plasma hormonal effects of SS-14 but is several times less potent than SS-14 in terms of circulating hormone levels.

AB - This study was designed to determine the influence of cephalic and gastrointestinal meal stimulation on plasma levels of somatostatin-like immunoreactivity (SLI) and to compare plasma hormonal and gastric secretory effects of somatostatin-14 (SS-14) and its putative prohormone, somatostatin-28 (SS-28), in humans. Cephalic stimulation induced by modified sham feeding did not affect plasma SLI, whereas a gastric liver extract meal caused a significant increase in SLI. Infusion of SS-28 dose-dependently suppressed gastric acid, serum gastrin, and plasma pancreatic polypeptide (PP) responses to cephalic and gastrointestinal stimulation. SS-28 was equipotent with SS-14 as gastric inhibitor when compared on the basis of molar doses infused but was 4-10 times less potent on the basis of plasma SLI concentrations obtained. A lower and more physiological dose of SS-14 (75 pmol/kg-h) reduced gastric acid and PP responses but failed to affect the serum gastrin response to a meal, whereas a larger, pharmacological dose (500 pmol/kg-h) also suppressed serum gastrin responses. We conclude that meal releases SLI into the circulation and that SS-28 mimics the gastric secretory and plasma hormonal effects of SS-14 but is several times less potent than SS-14 in terms of circulating hormone levels.

KW - Cephalic phase

KW - Gastric secretion

KW - Gastrointestinal hormones

KW - Somatostatin

UR - http://www.scopus.com/inward/record.url?scp=0021911331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021911331&partnerID=8YFLogxK

U2 - 10.3109/00365528509089629

DO - 10.3109/00365528509089629

M3 - Article

VL - 20

SP - 31

EP - 38

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

SN - 0036-5521

IS - 1

ER -